Inhibition of Monoamine Oxidases Desensitizes 5-HT1AAutoreceptors and Allows Nicotine to Induce a Neurochemical and Behavioral Sensitization
Open Access
- 28 January 2009
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (4), 987-997
- https://doi.org/10.1523/jneurosci.3315-08.2009
Abstract
Although nicotine is generally considered to be the main compound responsible for addictive properties of tobacco, experimental data indicate that nicotine does not exhibit all the characteristics of other substances of abuse. We recently showed that a pretreatment with mixed irreversible monoamine oxidases inhibitors (MAOIs), such as tranylcypromine, triggers a locomotor response to nicotine in mice and allows maintenance of behavioral sensitization to nicotine in rats. Moreover, we showed by microdialysis in mice that behavioral sensitization induced by compounds belonging to main groups of drugs of abuse, such as amphetamine, cocaine, morphine, or alcohol, was underlain by sensitization of noradrenergic and serotonergic neurons. Here, this neurochemical sensitization was tested after nicotine, tranylcypromine, or a mixture of both compounds. Data indicate that, whereas neither repeated nicotine nor repeated tranylcypromine alone has any effect by itself, a repeated treatment with a mixture of nicotine and tranylcypromine induces both behavioral sensitization and sensitization of noradrenergic and serotonergic neurons. The development of neurochemical and behavioral sensitizations is blocked by prazosin and SR46349B [(1Z,2E)-1-(2-fluoro-phenyl)-3-(4-hydroxyphenyl)-prop-2-en-one-O-(2-dimethylamino-ethyl)-oxime hemifumarate], two antagonists of α1b-adrenergic and 5-HT2Areceptors, respectively, but not by SCH23390 [R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride], a D1receptor antagonist. Finally, we found that pretreatments with WAY 100635 [N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclo-hexane carboxamide trihydrochloride], a 5-HT1Areceptor antagonist, can also induce a behavioral and neurochemical sensitization to repeated nicotine. Complementary experiments with 8-OHDPAT (8-hydroxy-dipropylamino-tetralin), a 5-HT1Areceptor agonist, and analysis of 5-HT1Areceptors expression in the dorsal raphe nucleus after a tranylcypromine injection indicate that MAOIs contained in tobacco desensitize 5-HT1Aautoreceptors to trigger the strong addictive properties of tobacco.Keywords
This publication has 57 references indexed in Scilit:
- Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in miceEuropean Journal of Neuroscience, 2006
- Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neuronsProceedings of the National Academy of Sciences, 2006
- Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to NicotineNeuropsychopharmacology, 2005
- Monoamine Oxidase Inhibition Dramatically Increases the Motivation to Self-Administer Nicotine in RatsJournal of Neuroscience, 2005
- Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approachAddiction, 2005
- 5‐HT2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulantsEuropean Journal of Neuroscience, 2004
- Molecular and Cellular Aspects of Nicotine AbuseNeuron, 1996
- Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smokingLife Sciences, 1996
- Nicotine induced excitation of locus coeruleus neurons is mediated via release of excitatory amino acidsLife Sciences, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970